<DOC>
	<DOCNO>NCT01444456</DOCNO>
	<brief_summary>This multicenter , international , prospective , observational study patient receive systemic chemotherapy solid tumour cancer ( breast , colorectal , ovarian , prostate , lung , bladder , endometrial , renal , pancreatic , esophageal gastric ) receive darbepoetin alfa ( Aranesp® ) erythropoiesis-stimulating agent ( ESA ) treat symptomatic anaemia . Quality Life assess electronically aim estimate improvement quality life patient receive darbepoetin alfa ( Aranesp® ) also increase haemoglobin ( Hb ) ≥1 g/dL</brief_summary>
	<brief_title>Assessment Quality Life Patients With Symptomatic Chemotherapy-induced Anaemia</brief_title>
	<detailed_description>Before enrol participant , country assign either cohort 1 ( patient receive darbepoetin alfa ) cohort 2 ( patient receive ESA ) . Cohort 2 assign country local regulation permit observational study participation patient receive specific agent drug class .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Darbepoetin alfa</mesh_term>
	<criteria>Diagnosed breast , colorectal , ovarian , prostate , lung , bladder , endometrial , renal , pancreatic , esophageal gastric cancer Expected receive least 8 additional week give regimen myelosuppressive chemotherapy enrolment Starting treatment either darbepoetin alfa ( Cohort 1 country ) ESA ( Cohort 2 country ) per European Summary Product Characteristics ( SPC ) symptomatic anaemia . Received ESA treatment Red Blood Cell ( RBC ) transfusion within 28 day prior enrolment Known primary benign malignant haematologic disorder cause anaemia Known hypersensitivity ESAs</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Breast Cancer</keyword>
	<keyword>Lung Cancer</keyword>
	<keyword>Ovarian Cancer</keyword>
	<keyword>Prostate Cancer</keyword>
	<keyword>Colorectal Cancer</keyword>
	<keyword>Aranesp</keyword>
	<keyword>Chemotherapy induce anaemia</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Bladder Cancer</keyword>
	<keyword>Endometrial Cancer</keyword>
	<keyword>Renal Cancer</keyword>
	<keyword>Pancreatic Cancer</keyword>
	<keyword>Esophageal Cancer</keyword>
	<keyword>Gastric Cancer</keyword>
</DOC>